SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001140361-19-018079
Filing Date
2019-10-07
Accepted
2019-10-07 19:23:07
Documents
1
Period of Report
2019-10-07

Document Format Files

Seq Description Document Type Size
1 FORM 4 form4.html 4  
1 FORM 4 form4.xml 4 5094
  Complete submission text file 0001140361-19-018079.txt   6389
Mailing Address 311 C ENTERPRISE DRIVE PLAINSBORO NJ 08536
Business Address
HENNEMAN JOHN B III (Reporting) CIK: 0001187572 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39069 | Film No.: 191141673

Mailing Address 535 BOYLSTON STREET BOSTON MA 02116
Business Address 535 BOYLSTON STREET BOSTON MA 02116 6095104718
Aprea Therapeutics, Inc. (Issuer) CIK: 0001781983 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences